Trial Review

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial details imported from ClinicalTrials.gov

For full trial details, please see the original record at https://clinicaltrials.gov/ct2/show/NCT01719055




Registration number
NCT01719055
Ethics application status
Date submitted
30/10/2012
Date registered
1/11/2012
Date last updated
7/06/2024

Titles & IDs
Public title
RELIEF - A Global Registry to Evaluate Long-Term Effectiveness of Neurostimulation Therapy for Pain
Scientific title
A Global Registry to Evaluate Long-Term Effectiveness of Neurostimulation Therapy for Pain
Secondary ID [1] 0 0
90876777
Secondary ID [2] 0 0
A7007
Universal Trial Number (UTN)
Trial acronym
RELIEF
Linked study record

Health condition
Health condition(s) or problem(s) studied:
Pain 0 0
Condition category
Condition code

Intervention/exposure
Study type
Observational
Patient registry
Target follow-up duration
Target follow-up type
Description of intervention(s) / exposure
Treatment: Devices - neurostimulation system

Boston Scientific SCS Systems - Subjects permanently implanted with a Boston Scientific neurostimulation systems


Treatment: Devices: neurostimulation system
Trial stimulation period, followed by permanent implant of a neurostimulation system for subjects with a positive trial outcome
Intervention code [1] 0 0
Treatment: Devices
Comparator / control treatment
Control group

Outcomes

Eligibility
Key inclusion criteria
Key

- Study candidate is scheduled to be trialed, on-label, with a commercially approved
Boston Scientific neurostimulation system for pain, per local directions for use

- Signed a valid, IRB/EC-approved informed consent form

- 18 years of age or older

Key
Minimum age
18 Years
Maximum age
No limit
Sex
Both males and females
Can healthy volunteers participate?
No
Key exclusion criteria
- Contraindicated for Boston Scientific neurostimulation system

- Currently diagnosed with cognitive impairment, or exhibits any characteristic, that
would limit study candidate's ability to assess pain relief or to complete study
assessments

Study design
Purpose
Duration
Selection
Timing
Prospective
Statistical methods / analysis

Recruitment
Recruitment status
Recruiting
Data analysis
Reason for early stopping/withdrawal
Other reasons
Date of first participant enrolment
Anticipated
Actual
19/11/2012
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
1/10/2027
Actual
Sample size
Target
4800
Accrual to date
Final
Recruitment in Australia
Recruitment state(s)
Recruitment hospital [1] 0 0
Interventus Pain Specialists - Auchenflower
Recruitment hospital [2] 0 0
Hunter Clinical Research - Broadmeadow
Recruitment hospital [3] 0 0
Hunter Pain Clinic - Broadmeadow
Recruitment hospital [4] 0 0
Green Lizard Science - Claremont
Recruitment hospital [5] 0 0
Sydney Spine and Pain Pty Ltd - Hurstville
Recruitment hospital [6] 0 0
Sunshine Coast Clinical Research - Noosa Heads
Recruitment hospital [7] 0 0
Pain Matrix - Waurn Ponds
Recruitment hospital [8] 0 0
Pain Medicine of South Australia - Wayville
Recruitment postcode(s) [1] 0 0
- Auchenflower
Recruitment postcode(s) [2] 0 0
- Broadmeadow
Recruitment postcode(s) [3] 0 0
- Claremont
Recruitment postcode(s) [4] 0 0
- Hurstville
Recruitment postcode(s) [5] 0 0
- Noosa Heads
Recruitment postcode(s) [6] 0 0
- Waurn Ponds
Recruitment postcode(s) [7] 0 0
- Wayville
Recruitment outside Australia
Country [1] 0 0
United States of America
State/province [1] 0 0
Arizona
Country [2] 0 0
United States of America
State/province [2] 0 0
California
Country [3] 0 0
United States of America
State/province [3] 0 0
Florida
Country [4] 0 0
United States of America
State/province [4] 0 0
Georgia
Country [5] 0 0
United States of America
State/province [5] 0 0
Illinois
Country [6] 0 0
United States of America
State/province [6] 0 0
Indiana
Country [7] 0 0
United States of America
State/province [7] 0 0
Kansas
Country [8] 0 0
United States of America
State/province [8] 0 0
Kentucky
Country [9] 0 0
United States of America
State/province [9] 0 0
Louisiana
Country [10] 0 0
United States of America
State/province [10] 0 0
Massachusetts
Country [11] 0 0
United States of America
State/province [11] 0 0
Michigan
Country [12] 0 0
United States of America
State/province [12] 0 0
Mississippi
Country [13] 0 0
United States of America
State/province [13] 0 0
Missouri
Country [14] 0 0
United States of America
State/province [14] 0 0
Nevada
Country [15] 0 0
United States of America
State/province [15] 0 0
New York
Country [16] 0 0
United States of America
State/province [16] 0 0
North Carolina
Country [17] 0 0
United States of America
State/province [17] 0 0
Ohio
Country [18] 0 0
United States of America
State/province [18] 0 0
Oregon
Country [19] 0 0
United States of America
State/province [19] 0 0
South Carolina
Country [20] 0 0
United States of America
State/province [20] 0 0
Texas
Country [21] 0 0
United States of America
State/province [21] 0 0
Washington
Country [22] 0 0
United States of America
State/province [22] 0 0
West Virginia
Country [23] 0 0
United States of America
State/province [23] 0 0
Wisconsin
Country [24] 0 0
Argentina
State/province [24] 0 0
Ciudad Autonoma de Buenos Aires
Country [25] 0 0
Belgium
State/province [25] 0 0
Gent
Country [26] 0 0
Belgium
State/province [26] 0 0
Roeselare
Country [27] 0 0
Canada
State/province [27] 0 0
London
Country [28] 0 0
Canada
State/province [28] 0 0
Québec
Country [29] 0 0
Canada
State/province [29] 0 0
Regina
Country [30] 0 0
Colombia
State/province [30] 0 0
Cali
Country [31] 0 0
Colombia
State/province [31] 0 0
Floridablanca
Country [32] 0 0
Denmark
State/province [32] 0 0
Odense
Country [33] 0 0
Germany
State/province [33] 0 0
Berlin
Country [34] 0 0
Germany
State/province [34] 0 0
Bonn
Country [35] 0 0
Germany
State/province [35] 0 0
Duesseldorf
Country [36] 0 0
Germany
State/province [36] 0 0
Koeln
Country [37] 0 0
Germany
State/province [37] 0 0
Köln
Country [38] 0 0
Germany
State/province [38] 0 0
München
Country [39] 0 0
Israel
State/province [39] 0 0
Ramat-Gan
Country [40] 0 0
Israel
State/province [40] 0 0
Tel Aviv
Country [41] 0 0
Italy
State/province [41] 0 0
Pavia
Country [42] 0 0
Italy
State/province [42] 0 0
Pisa
Country [43] 0 0
Japan
State/province [43] 0 0
Kobe-shi
Country [44] 0 0
Japan
State/province [44] 0 0
Nishinomiya-shi
Country [45] 0 0
Japan
State/province [45] 0 0
Okayama-shi
Country [46] 0 0
Japan
State/province [46] 0 0
Sakai-shi
Country [47] 0 0
Netherlands
State/province [47] 0 0
Velp
Country [48] 0 0
Spain
State/province [48] 0 0
Ciudad Real
Country [49] 0 0
Spain
State/province [49] 0 0
Madrid
Country [50] 0 0
Spain
State/province [50] 0 0
Pamplona
Country [51] 0 0
Spain
State/province [51] 0 0
San Sebastián
Country [52] 0 0
Spain
State/province [52] 0 0
Santander
Country [53] 0 0
Spain
State/province [53] 0 0
Toledo
Country [54] 0 0
Spain
State/province [54] 0 0
Valencia
Country [55] 0 0
Sweden
State/province [55] 0 0
Göteborg
Country [56] 0 0
Switzerland
State/province [56] 0 0
Viganello
Country [57] 0 0
United Kingdom
State/province [57] 0 0
Basildon
Country [58] 0 0
United Kingdom
State/province [58] 0 0
Bristol
Country [59] 0 0
United Kingdom
State/province [59] 0 0
Leeds
Country [60] 0 0
United Kingdom
State/province [60] 0 0
London
Country [61] 0 0
United Kingdom
State/province [61] 0 0
Stanmore

Funding & Sponsors
Primary sponsor type
Commercial sector/Industry
Name
Boston Scientific Corporation
Address
Country

Ethics approval
Ethics application status

Summary
Brief summary
To compile characteristics of real-world clinical outcomes for Boston Scientific commercially
approved neurostimulation systems for pain in routine clinical practice, when used according
to the applicable Directions for Use

- and -

To evaluate the economic value and technical performance of Boston Scientific commercially
approved neurostimulation systems for pain in routine clinical practice
Trial website
https://clinicaltrials.gov/ct2/show/NCT01719055
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 0 0
Natalie Bloom Lyons
Address 0 0
Boston Scientific Corporation
Country 0 0
Phone 0 0
Fax 0 0
Email 0 0
Contact person for public queries
Name 0 0
Gerard Herro, MS
Address 0 0
Country 0 0
Phone 0 0
855-213-9890
Fax 0 0
Email 0 0
[email protected]
Contact person for scientific queries



Summary Results

For IPD and results data, please see https://clinicaltrials.gov/ct2/show/NCT01719055